Similar articles for PMID: 19553857

Year	Number of Results
1977	1
1983	1
1994	2
1996	1
1998	1
1999	1
2000	1
2001	1
2002	8
2003	4
2004	6
2005	10
2006	18
2007	15
2008	23
2009	34
2010	11
2011	15
2012	12
2013	12
2014	14
2015	8
2016	17
2017	17
2018	8
2019	11
2020	11
2021	14
2022	22
2023	7

1

Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature.

Poldervaart MT, Breugem CC, Speleman L, Pasmans S. Poldervaart MT, et al. J Craniofac Surg. 2009 Jul;20(4):1159-62. doi: 10.1097/SCS.0b013e3181abb249. J Craniofac Surg. 2009. PMID: 19553857 Review.

2

Efficacy and safety of OK-432 immunotherapy of lymphatic malformations.

Smith MC, Zimmerman MB, Burke DK, Bauman NM, Sato Y, Smith RJ; OK-432 Collaborative Study Group. Smith MC, et al. Laryngoscope. 2009 Jan;119(1):107-15. doi: 10.1002/lary.20041. Laryngoscope. 2009. PMID: 19117316 Clinical Trial.

3

Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.

Chen WL, Huang ZQ, Chai Q, Zhang DM, Wang YY, Wang HJ, Wang L, Fan S. Chen WL, et al. Int J Oral Maxillofac Surg. 2011 Jun;40(6):572-6. doi: 10.1016/j.ijom.2011.01.009. Epub 2011 Mar 1. Int J Oral Maxillofac Surg. 2011. PMID: 21367582

4

Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy.

Peters DA, Courtemanche DJ, Heran MKS, Ludemann JP, Prendiville JS. Peters DA, et al. Plast Reconstr Surg. 2006 Nov;118(6):1441-1446. doi: 10.1097/01.prs.0000239503.10964.11. Plast Reconstr Surg. 2006. PMID: 17051116

5

Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children.

Nehra D, Jacobson L, Barnes P, Mallory B, Albanese CT, Sylvester KG. Nehra D, et al. J Pediatr Surg. 2008 Mar;43(3):451-60. doi: 10.1016/j.jpedsurg.2007.10.009. J Pediatr Surg. 2008. PMID: 18358281

6

Multimodality treatment of pediatric lymphatic malformations of the head and neck using surgery and sclerotherapy.

Boardman SJ, Cochrane LA, Roebuck D, Elliott MJ, Hartley BE. Boardman SJ, et al. Arch Otolaryngol Head Neck Surg. 2010 Mar;136(3):270-6. doi: 10.1001/archoto.2010.6. Arch Otolaryngol Head Neck Surg. 2010. PMID: 20231646

7

Percutaneous treatment of lymphatic malformations.

Shiels WE 2nd, Kang DR, Murakami JW, Hogan MJ, Wiet GJ. Shiels WE 2nd, et al. Otolaryngol Head Neck Surg. 2009 Aug;141(2):219-24. doi: 10.1016/j.otohns.2009.04.001. Otolaryngol Head Neck Surg. 2009. PMID: 19643255

8

Lymphatic Malformation Architecture: Implications for Treatment With OK-432.

Malic CC, Guilfoyle R, Courtemanche RJM, Arneja JS, Heran MKS, Courtemanche DJ. Malic CC, et al. J Craniofac Surg. 2017 Oct;28(7):1721-1724. doi: 10.1097/SCS.0000000000003789. J Craniofac Surg. 2017. PMID: 28834841

9

Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck.

Sung MW, Lee DW, Kim DY, Lee SJ, Hwang CH, Park SW, Kim KH. Sung MW, et al. Laryngoscope. 2001 Aug;111(8):1430-3. doi: 10.1097/00005537-200108000-00020. Laryngoscope. 2001. PMID: 11568580

10

OK-432 sclerotherapy of lymphatic malformation in the head and neck: factors related to outcome.

Kim DW. Kim DW. Pediatr Radiol. 2014 Jul;44(7):857-62. doi: 10.1007/s00247-014-2889-0. Epub 2014 Feb 26. Pediatr Radiol. 2014. PMID: 24569928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

267 results

Results by year